StockNews.com assumed coverage on shares of Bellerophon Therapeutics (NASDAQ:BLPH – Free Report) in a report released on Sunday. The firm issued a hold rating on the biotechnology company’s stock.
Bellerophon Therapeutics Stock Performance
Shares of NASDAQ:BLPH remained flat at $0.05 during trading on Friday. Bellerophon Therapeutics has a 52-week low of $0.03 and a 52-week high of $0.52. The firm has a market cap of $623,730.00, a price-to-earnings ratio of -0.06 and a beta of 0.73. The stock’s 50 day simple moving average is $0.06 and its two-hundred day simple moving average is $0.06.
Bellerophon Therapeutics Company Profile
Read More
- Five stocks we like better than Bellerophon Therapeutics
- Transportation Stocks Investing
- From Tokyo to Wall Street: Japan’s Market Impact on U.S. Stocks
- Want to Profit on the Downtrend? Downtrends, Explained.
- Arm Holdings: Does the 42% Drop Signal an AI Buying Opportunity?
- What is the S&P/TSX Index?
- Texas Roadhouse Stampedes On EPS Beat as Comp Sales Surge 9.3%
Receive News & Ratings for Bellerophon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bellerophon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
